SUDARSHAN PHARMA INDUSTRIES
Back to Balance Sheet
|
SUDARSHAN PHARMA INDUSTRIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹75 Cr | ₹77 Cr | ₹80 Cr | ₹27 Cr | ₹16 Cr |
What is the latest Net Current Assets ratio of SUDARSHAN PHARMA INDUSTRIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹75 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹80 Cr |
| Mar2022 | ₹27 Cr |
| Mar2021 | ₹16 Cr |
How is Net Current Assets of SUDARSHAN PHARMA INDUSTRIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹75 Cr | -2.05 | |
| Mar2024 | ₹77 Cr | -4.26 | |
| Mar2023 | ₹80 Cr | 197.33 | |
| Mar2022 | ₹27 Cr | 64.14 | |
| Mar2021 | ₹16 Cr | - | |
Compare Net Current Assets of peers of SUDARSHAN PHARMA INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDARSHAN PHARMA INDUSTRIES | ₹828.9 Cr | -8% | -14.8% | 27% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,831.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,074.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,355.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹107,439.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,417.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
SUDARSHAN PHARMA INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDARSHAN PHARMA INDUSTRIES | -8% |
-14.8% |
27% |
| SENSEX | 0.6% |
-1.4% |
-10.7% |
You may also like the below Video Courses